Clinical Trial: A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07082738) titled 'A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease' on June 11.

Brief Summary: This Phase IIb dose-ranging study will evaluate the efficacy and safety of 3 different doses of AZD6793 compared with placebo tablets in participants with moderate to very severe chronic obstructive pulmonary disease.

Study Start Date: June 27

Study Type: INTERVENTIONAL

Condition: Chronic Obstructive Pulmonary Disease (COPD)

Intervention: DRUG: AZD6793

Oral dosage

OTHER: Placebo

Oral dosage

Recruitment Status: RECRUITING

Sponsor: AstraZeneca

Published by HT Digital Co...